Read Time:7 Second
Crispr Therapeutics and Vertex Pharmaceuticals got U.S. regulatory approval for a sickle-cell disease treatment based on the gene-editing technology Crispr.
Happy
0 %
Sad
0 %
Excited
0 %
Sleepy
0 %
Angry
0 %
Surprise
0 %
0
0
